Biotech

All Articles

Nuvation halts wager prevention after considering phase 1 record

.After looking at stage 1 record, Nuvation Biography has chosen to halt service its single lead BD2-...

' Clinical intuition' led FDA advisors to support Zevra's uncommon condition med

.Zevra Therapeutics' rare condition drug seems to be to become on the road to confirmation this loss...

Pfizer takes $230M struck after axing neglected DMD gene therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene therapy failing has blown a $230 million open...

AC Immune observes 'site' prospective in Alzheimer's drug information

.After greater than two decades of work with neurodegenerative health conditions, Swiss biotech air ...

GSK loses ph. 2 HPV vaccination over shortage of best-in-class potential

.GSK has broken up a period 2 human papillomavirus (HPV) vaccination from its pipeline after determi...

OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies will certainly provide on the NYSE American stock exchange this morning ...

ALX's fizzling CD47 feedback price delivers inventory spiraling down

.ALX Oncology's phase 2 stomach cancer reaction cost has damaged. After seeing its own CD47 blocker ...

Ionis centers eye ailment from intendeds of Roche-partnered possibility after data let down

.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of requirements, p...

Biogen's chief executive officer mentioned no risky sell 2023. He prepares to become bold

.While Biogen's pharma peers are actually looking for late-stage possessions with little bit of dang...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Biography has been actually a biotech looking for a pipe after it scrapped its own lead poss...